CEO Geoff Martha said Medtronic would submit its application for urological procedures to the Food and Drug Administration by ...

The massive robot-making, pacemaker-inventing medtech company Medtronic is facing a financial snag: the humble stapler.

Discover why Medtronic's growth in robotics, AI, & solid fundamentals make it a Buy ahead of earnings. Read my analysis here.

Bogle, Medtronic’s head of medical affairs for digital surgery, also discussed the company’s plans to train surgeons for its ...

Medtronic’s Hugo™ robotic-assisted surgery system is modular and portable for flexibility and efficiency across surgeries. Our team redesigned the Sterile Interface Module, which separates Hugo’s arm ...

With the release of da Vinci 5, Intuitive is preempting moves from key competitors such as Medtronic, whose Hugo robot launched in Europe in 2021 and is available in 25 countries worldwide.

Medtronic CEO Geoff Martha told investors in November that the company plans to make a submission to the Food and Drug Administration for its Hugo robot in the first quarter of this year.

Second, the healthcare giant is developing a robotic-assisted surgery (RAS) device, the Hugo system ... surgeries that robot systems allow physicians to perform. Beyond that, Medtronic should ...